• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    75 Biggest Movers From Yesterday

    3/22/22 4:42:32 AM ET
    $AA
    $AAMC
    $AKAN
    $ALLR
    Aluminum
    Industrials
    Real Estate
    Finance
    Get the next $AA alert in real time by email

    Gainers

    • NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) gained 58.4% to settle at $1.22. Clarus Therapeutics recently reported initiation of Phase 4 trial of JATENZO for treatment of hypogonadal men with chronic kidney disease.
    • Yumanity Therapeutics, Inc. (NASDAQ:YMTX) shares surged 58% to settle at $1.77.
    • Ipsidy Inc. (NASDAQ:AUID) gained 54.1% to settle at $4.67. authID.ai reported 2021 revenue of $2.3 million, up from $2.1 million year over year.
    • BitNile Holdings, Inc. (NYSE:NILE) gained 48.6% to close at $0.83. BitNile's TurnOnGreen resumed expansion of its electric vehicle charging network and e-commerce operations.
    • United Time Technology Co., Ltd. (NASDAQ:UTME) shares climbed 44.8% to close at $2.78 following a 12% surge on Friday.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) surged 44% to settle at $1.44.
    • Cyren Ltd. (NASDAQ:CYRN) jumped 43.2% to settle at $9.08 following a statement from U.S. President Joe Biden calling for increased cybersecurity measures.
    • PainReform Ltd. (NASDAQ:PRFX) surged 39.6% to close at $1.55. PainReform recently reported a FY21 net loss of $7.2 million.

    Check out our premarket coverage here .

    • BT Brands, Inc. (NASDAQ:BTBD) gained 38.7% to close at $2.15 after dropping 39% on Friday. BT Brands recently posted Q4 sales of $1.85 million.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) jumped 38% to close at $0.4556 after declining more than 22% on Friday.
    • O2Micro International Limited (NASDAQ:OIIM) gained 34.4% to close at $4.34. O2Micro reported the receipt of a preliminary non-binding proposal to acquire the company.
    • Qutoutiao Inc. (NASDAQ:QTT) gained 32.8% to settle at $2.35.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) gained 28.8% to close at $0.2641 after dipping around 32% on Friday.
    • Scopus BioPharma Inc. (NASDAQ:SCPS) rose 28.3% to settle at $0.8205.
    • Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) gained 28.1% to settle at $1.15. The company recently posted a narrower-than-expected quarterly loss.
    • Anaplan, Inc. (NYSE:PLAN) climbed 27.7% to close at $64.60 as the company agreed to be acquired by Thoma Bravo in an all-cash deal valued at around $10.7 billion.
    • Hudson Capital Inc. (NASDAQ:HUSN) shares rose 27.1% to settle at $2.63. Hudson Capital said its Fr8PrivateFleet product secured new and existing customers, including one of Mexico’s largest food producers.
    • Cadiz Inc. (NASDAQ:CDZI) rose 26.8% to close at $2.22 after the company announced a new $12 million equity investment from a registered direct offering of 6.86 million shares of common stock at $1.75 per share.
    • Cenntro Electric Group Limited (NASDAQ:CENN) gained 26.4% to settle at $2.2750.
    • Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) gained 26.2% to settle at $7.56 following a statement from U.S. President Joe Biden calling for increased cybersecurity measures.
    • SuperCom Ltd. (NASDAQ:SPCB) jumped 25.7% to close at $0.6915.
    • Alleghany Corporation (NYSE:Y) gained 24.8% to close at $844.60 after Berkshire Hathaway announced it would acquire the company for $848.02/share.
    • SecureWorks Corp. (NASDAQ:SCWX) surged 24.7% to settle at $13.26. Goldman Sachs and Morgan Stanley lowered their price targets on the stock.
    • Fast Radius, Inc. (NASDAQ:FSRD) gained 24.6% to settle at $1.67. Fast Radius recently named Erin Stone as General Counsel and Corporate Secretary, and James Erkenswick as Chief Accounting Officer.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) rose 23.8% to close at $3.07 after jumping 5% on Friday.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) gained 23.7% to settle at $1.83. Quoin Pharmaceuticals recently announced submission of IND for QRX003 for Netherton Syndrome.
    • IZEA Worldwide, Inc. (NASDAQ:IZEA) jumped 23.6% to close at $1.31.
    • Heliogen, Inc. (NASDAQ:HLGN) gained 22.2% to settle at $6.01.
    • LogicMark, Inc. (NASDAQ:LGMK) climbed 22% to close at $2.88.
    • Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) rose 21.9% to close at $1.56.
    • Intrepid Potash, Inc. (NYSE:IPI) jumped 21.6% to close at $84.04.
    • EuroDry Ltd. (NASDAQ:EDRY) rose 21.2% to settle at $29.59.
    • NEXGEL, Inc. (NASDAQ:NXGL) gained 20.5% to close at $2.06. NexGel (NASDAQ:NXGL) reported $533.00 thousand in sales for the fourth quarter.
    • Zosano Pharma Corporation (NASDAQ:ZSAN) climbed 20.3% to close at $0.2147. Zosano Pharma recently reduced 31% of its staff as the FDA rejected its already-rejected migraine drug last month.
    • Zenvia Inc. (NASDAQ:ZENV) rose 20.2% to settle at $5.71. Zenvia, last week, reported Q4 adjusted gross profit of R$62.1 million.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) gained 19.9% to close at $9.22.
    • OneConnect Financial Technology Co., Ltd. (NYSE:OCFT) jumped 18.4% to close at $1.67.
    • Sera Prognostics, Inc. (NASDAQ:SERA) climbed 17.6% to settle at $3.48.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 17.6% to close at $2.27.
    • Cognyte Software Ltd. (NASDAQ:CGNT) gained 17.1% to close at $12.34. Stifel maintained Cognyte Software with a Buy and lowered the price target from $26 to $21.
    • Akanda Corp. (NASDAQ:AKAN) rose 13.7% to close at $8.41.
    • MarketWise, Inc. (NASDAQ:MKTW) shares rose 12.9% to settle at $5.00. The company recently posted upbeat quarterly sales.
    • Owlet, Inc. (NYSE:OWLT) gained 11.9% to close at $3.58.
    • Jowell Global Ltd. (NASDAQ:JWEL) surged 11.7% to close at $2.38.
    • Century Aluminum Company (NASDAQ:CENX) jumped 11.1% to close at $27.09.
    • Mullen Automotive, Inc. (NASDAQ:MULN) rose 10.7% to close at $3.21 after jumping around 19% on Friday.
    • Alcoa Corporation (NYSE:AA) surged 10% to close at $90.69. Argus Research maintained Alcoa with a Buy and raised the price target from $68 to $95.


    Losers

    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares tumbled 69% to close at $2.31 on Monday after releasing topline results from its Phase 1 SEAL study evaluating ADAIR, an abuse-deterrent formulation of immediate-release (IR) dextroamphetamine for attention deficit hyperactivity disorder (ADHD). The study did not meet its primary endpoint, Emax Drug Liking. ADAIR scored similarly to what was observed in an earlier proof-of-concept study.
    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) shares dipped 43.2% to close at $0.2750 after the company said it would terminate its URIROX-2 Study to reduce kidney stone disease progression.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) dipped 36.7% to settle at $1.50 after the company announced an upsized public offering of 37.5 million units at $1.60 per unit.
    • Hour Loop, Inc. (NASDAQ:HOUR) dropped 32.8% to close at $3.60.
    • Jewett-Cameron Trading Company Ltd. (NASDAQ:JCTCF) fell 25.6% to settle at $5.76.
    • CinCor Pharma, Inc. (NASDAQ:CINC) dropped 25.1% to close at $14.82.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) fell 24.4% to settle at $7.79.
    • BEST Inc. (NYSE:BEST) fell 24.2% to close at $0.7582 after jumping over 73% on Friday.
    • Connect Biopharma Holdings Limited (NASDAQ:CNTB) fell 23.4% to close at $3.79.
    • Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:LVLU) dipped 23.4% to close at $5.67.
    • Nuvectis Pharma, Inc. (NASDAQ:NVCT) declined 23% to close at $6.03.
    • Boxed, Inc. (NYSE:BOXD) fell 20.8% to close at $8.04. Boxed recently posted Q4 loss of $1.64 per share.
    • 17 Education & Technology Group Inc. (NASDAQ:YQ) fell 20.6% to close at $3.00.
    • Sonim Technologies, Inc. (NASDAQ:SONM) dipped 20.2% to settle at $1.03. Sonim Technologies posted Q4 sales of $15.9 million.
    • ImmunoGen, Inc. (NASDAQ:IMGN) fell 18.3% to close at $3.79 after the company announced full results from the pivotal SORAYA trial of mirvetuximab soravtansine in ovarian cancer at the SGO annual meeting. Also, RBC Capital downgraded the stock from Outperform to Sector Perform and lowered its price target from $9 to $6.
    • Telesat Corporation (NASDAQ:TSAT) declined 17.9% to close at $18.81. Telesat recently posted FY 2021 adjusted EBITDA of C$603 million.
    • Sutro Biopharma, Inc. (NASDAQ:STRO) fell 17.8% to close at $7.97.
    • Zhihu Inc. (NYSE:ZH) fell 17.7% to close at $2.60 after jumping 55% on Friday.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) fell 16.4% to close at $1.07. TC BioPharm recently said FDA orphan drug status was granted for OmniImmune.
    • EQRx, Inc. (NASDAQ:EQRX) dipped 14.7% to close at $3.54. EQRx is scheduled to hold Q4 financial results conference call on Wednesday, March 23, 2022.
    • KE Holdings Inc. (NYSE:BEKE) fell 14.1% to close at $12.15.
    • Shopify Inc. (NYSE:SHOP) fell 12.4% to close at $683.45, possibly selling off following a rally heading into Friday's close.
    • Altisource Asset Management Corporation (NYSE:AAMC) fell 12% to close at $15.75.
    • Color Star Technology Co., Ltd. (NASDAQ:CSCW) fell 11.2% to close at $0.2366 after gaining 8% on Friday.
    • MOGU Inc. (NYSE:MOGU) shares fell 10.6% to settle at $0.3089 after climbing 23% on Friday.
    • Palisade Bio, Inc. (NASDAQ:PALI) fell 8.5% to settle at $0.8050. Palisade recently reported cash and cash equivalents as of Dec. 31, 2021 of $10.5 million.
    • China Eastern Airlines Corporation Limited (NYSE:CEA) shares fell 6.3% to close at $17.83. A China Eastern Airlines Boeing Co. (NYSE:BA) 737-800NG plane carrying 132 people crashed in China’s southwestern province of Guangxi, reported Bloomberg.
    Get the next $AA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AA
    $AAMC
    $AKAN
    $ALLR

    CompanyDatePrice TargetRatingAnalyst
    Palisade Bio Inc.
    $PALI
    2/25/2026$5.00Buy
    Stifel
    Shopify Inc.
    $SHOP
    2/17/2026$150.00Hold → Buy
    Truist
    EuroDry Ltd.
    $EDRY
    2/12/2026$23.50Market Perform → Outperform
    Noble Capital Markets
    Shopify Inc.
    $SHOP
    2/12/2026$150.00Neutral → Outperform
    Mizuho
    Shopify Inc.
    $SHOP
    2/12/2026$159.00Hold → Buy
    TD Cowen
    Shopify Inc.
    $SHOP
    2/10/2026$150.00Neutral → Buy
    MoffettNathanson
    KE Holdings Inc
    $BEKE
    2/3/2026$19.00Buy → Neutral
    Goldman
    CADIZ Inc.
    $CDZI
    2/2/2026$10.00Buy
    Maxim Group
    More analyst ratings

    $AA
    $AAMC
    $AKAN
    $ALLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Gov Ops, GPP & CS Shockey Jeffrey S covered exercise/tax liability with 4,444 shares, decreasing direct ownership by 16% to 23,294 units (SEC Form 4)

    4 - BOEING CO (0000012927) (Issuer)

    2/26/26 7:27:49 PM ET
    $BA
    Aerospace
    Industrials

    EVP and Chief HR Officer Amuluru Uma M sold $351,484 worth of shares (1,503 units at $233.78), decreasing direct ownership by 7% to 19,015 units (SEC Form 4)

    4 - BOEING CO (0000012927) (Issuer)

    2/26/26 7:21:47 PM ET
    $BA
    Aerospace
    Industrials

    EVP, GC and Secretary Dezee John sold $3,347,520 worth of shares (66,000 units at $50.72), decreasing direct ownership by 40% to 97,647 units (SEC Form 4)

    4 - CENTURY ALUMINUM CO (0000949157) (Issuer)

    2/25/26 6:04:21 PM ET
    $CENX
    Aluminum
    Industrials

    $AA
    $AAMC
    $AKAN
    $ALLR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    First Towers & Fiber Corp. Owns the Largest Dark Fiber Network in Central Mexico

    Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - Akanda Corp. (NASDAQ:AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today plans to further expand the leasing of its approximately 700-kilometre dark fiber optic network located in Central Mexico. The network represents the largest dark fiber infrastructure in the region, serving several of Mexico's most active industrial corridors and fastest-growing state economies.The network was constructed following the execution of a 20-year long-term dark fiber lease agreement with Telefónica, the Spanish multinationa

    2/27/26 8:30:00 AM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Alcoa Corporation Declares Quarterly Cash Dividend

    Alcoa Corporation (NYSE:AA, ASX: AAI)) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share of the Company's common stock, to be paid on March 26, 2026 to stockholders of record as of the close of business on March 10, 2026. About Alcoa Corporation Alcoa is a global industry leader in bauxite, alumina and aluminum products with a vision to build a legacy of excellence for future generations. With a values-based approach that encompasses integrity, operating excellence, care for people, and courageous leadership, our purpose is to Turn Raw Potential into Real Progress. Since developing the process that made aluminum an affordable and vital

    2/26/26 5:25:00 PM ET
    $AA
    Aluminum
    Industrials

    NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome

    ASHBURN, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- In recognition of Rare Disease Day® 2026, Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) today highlighted the continued growth of its NETHERTON NOW awareness campaign, which seeks to amplify the voices of patients, caregivers and clinicians impacted by Netherton Syndrome, a rare genetic disease with no approved treatment or cure. Rare Disease Day, observed annually on the last day of February during Rare Disease Month, was established in 2008 by EURORDIS to raise awareness of rare conditions and the profound challenges faced by those living with them. While each rare disease affects a relatively small population, collectively rare diseases impact

    2/26/26 8:30:00 AM ET
    $QNRX
    Medical/Dental Instruments
    Health Care

    $AA
    $AAMC
    $AKAN
    $ALLR
    SEC Filings

    View All

    SEC Form 6-K filed by Akanda Corp.

    6-K - AKANDA CORP. (0001888014) (Filer)

    2/27/26 3:57:00 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 10-K filed by Alcoa Corporation

    10-K - Alcoa Corp (0001675149) (Filer)

    2/26/26 4:52:29 PM ET
    $AA
    Aluminum
    Industrials

    Dermata Therapeutics Inc. filed SEC Form 8-K: Leadership Update

    8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)

    2/25/26 4:05:32 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $AAMC
    $AKAN
    $ALLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williams Donald Allen bought $8,356 worth of shares (5,000 units at $1.67), increasing direct ownership by 87% to 10,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/21/26 4:05:24 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Williams Donald Allen bought $9,400 worth of shares (5,000 units at $1.88), increasing direct ownership by 687% to 5,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/13/26 9:43:07 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AA
    $AAMC
    $AKAN
    $ALLR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 26, 2024 - FDA Roundup: March 26, 2024

    For Immediate Release: March 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA proposed a ban of electrical stimulation devices intended to reduce or stop self-injurious or aggressive behavior, a step rarely taken by the agency. The agency has determined that these devices present an unreasonable and substantial risk of

    3/26/24 3:38:14 PM ET
    $IMGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ELAHERE issued to IMMUNOGEN INC

    Submission status for IMMUNOGEN INC's drug ELAHERE (SUPPL-5) with active ingredient MIRVETUXIMAB SORAVTANSINE-GYNX has changed to 'Approval' on 03/22/2024. Application Category: BLA, Application Number: 761310, Application Classification:

    3/22/24 1:48:21 PM ET
    $IMGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ELAHERE issued to IMMUNOGEN INC

    Submission status for IMMUNOGEN INC's drug ELAHERE (ORIG-1) with active ingredient MIRVETUXIMAB SORAVTANSINE-GYNX has changed to 'Approval' on 11/14/2022. Application Category: BLA, Application Number: 761310, Application Classification:

    11/15/22 5:01:07 PM ET
    $IMGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $AAMC
    $AKAN
    $ALLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Palisade Bio with a new price target

    Stifel initiated coverage of Palisade Bio with a rating of Buy and set a new price target of $5.00

    2/25/26 7:53:12 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Shopify upgraded by Truist with a new price target

    Truist upgraded Shopify from Hold to Buy and set a new price target of $150.00

    2/17/26 8:04:32 AM ET
    $SHOP
    Computer Software: Prepackaged Software
    Technology

    EuroDry upgraded by Noble Capital Markets with a new price target

    Noble Capital Markets upgraded EuroDry from Market Perform to Outperform and set a new price target of $23.50

    2/12/26 9:28:12 AM ET
    $EDRY
    Marine Transportation
    Consumer Discretionary

    $AA
    $AAMC
    $AKAN
    $ALLR
    Leadership Updates

    Live Leadership Updates

    View All

    CISO Global Appoints Dhaval Damania as EVP of Cybersecurity & IT

    Experienced AI and enterprise IT operations leader joins Company to accelerate scalable growth, strengthen security architecture, and advance next-generation cyber software innovation Scottsdale, Ariz., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Dhaval Damania as Executive Vice President of Cybersecurity & IT. This appointment reinforces its continued commitment to operational excellence, innovation, and scalable growth across its next-generation cybersecurity software portfolio. In this role, Damania will lead CISO Global's

    2/23/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    CISO Global Lands 30 Year Sales Veteran Michael Czerneda to Ignite the Next Wave of Software Growth

    New Vice President of Sales to accelerate software-driven growth across cyber services platform and insurance distribution channels  Scottsdale, Ariz., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Michael Czerneda as Vice President of Sales. In this role, Czerneda will lead enterprise-wide sales initiatives as the Company accelerates its transition toward scalable, software-driven growth built on its established cyber services platform.  Czerneda brings more than 30 years of sales leadership experience spanning UCaaS, CCaaS, da

    2/18/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary

    BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (NASDAQ:LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has appointed Sidney Braun as Chief Executive Officer of the Company's Liora Technologies Europe Ltd. subsidiary ("Liora"). A veteran of the healthcare industry, Braun brings to Liora more than two decades of operational and strategic advisory experience at companies in North America, Europe and Israel. He was instrumental in the creation of Liora and facilitated LIXTE's acquisition of Liora's assets in November 2025 from Orbit Capital, Inc. Over his

    2/18/26 8:00:00 AM ET
    $LIXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $AAMC
    $AKAN
    $ALLR
    Financials

    Live finance-specific insights

    View All

    Alcoa Corporation Declares Quarterly Cash Dividend

    Alcoa Corporation (NYSE:AA, ASX: AAI)) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share of the Company's common stock, to be paid on March 26, 2026 to stockholders of record as of the close of business on March 10, 2026. About Alcoa Corporation Alcoa is a global industry leader in bauxite, alumina and aluminum products with a vision to build a legacy of excellence for future generations. With a values-based approach that encompasses integrity, operating excellence, care for people, and courageous leadership, our purpose is to Turn Raw Potential into Real Progress. Since developing the process that made aluminum an affordable and vital

    2/26/26 5:25:00 PM ET
    $AA
    Aluminum
    Industrials

    Intrepid Announces Date for Fourth Quarter and Full Year 2025 Earnings Release

    Intrepid Potash, Inc. (NYSE:IPI) plans to release its fourth quarter and full year 2025 financial results on Wednesday, March 4, 2026, after the market closes. Intrepid will host a conference call on Thursday, March 5, 2026, at 12:00 p.m. Eastern Time to discuss the results and other operating and financial matters and answer investor questions. Management invites you to listen to the conference call by using the toll-free dial-in number 1 (800) 715-9871 or International dial-in number 1 (646) 307-1963; please use conference ID 1179359. The call will also be streamed live via webcast. A recording of the conference call will be available approximately two hours after the completion of th

    2/20/26 8:30:00 AM ET
    $IPI
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    Century Aluminum Company Reports Fourth Quarter 2025 Results

    CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) today announced its fourth quarter and full year 2025 results. Fourth Quarter 2025 Highlights Net sales of $633.7 millionReported net income attributable to Century stockholders of $1.8 million, or $0.02 per diluted share; Adjusted net income attributable to Century stockholders of $128.2 million1, or $1.25 per share; Adjusted EBITDA attributable to Century stockholders of $170.6 million1Ending cash and cash equivalents of $134.2 million and strong liquidity of $418.0 million at December 31, 2025 Full Year 2025 Highlights Net sales of $2.5 billionReported net income attributable to Century stockholders of

    2/19/26 4:05:00 PM ET
    $CENX
    Aluminum
    Industrials

    $AA
    $AAMC
    $AKAN
    $ALLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NeuroSense Therapeutics Ltd.

    SC 13G - NeuroSense Therapeutics Ltd. (0001875091) (Subject)

    12/9/24 4:00:18 PM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by CADIZ Inc.

    SC 13G/A - CADIZ INC (0000727273) (Subject)

    12/6/24 6:52:25 PM ET
    $CDZI
    Water Supply
    Utilities

    Amendment: SEC Form SC 13G/A filed by SecureWorks Corp.

    SC 13G/A - SecureWorks Corp (0001468666) (Subject)

    12/6/24 3:33:53 PM ET
    $SCWX
    Computer Software: Prepackaged Software
    Technology